SCHEMBL22179952

SCHEMBL22179952

Cc1ncnc2ccc(-c3nnc(NC(=O)N(C)Cc4ccccn4)nc3-c3ccc(F)cc3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.41
▸ CTNNB1 P35222 1/20 0.37
▸ TCF7L2 Q9NQB0 1/20 0.37
▸ LMNA P02545 3/20 0.36
▸ USP2 O75604 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CLK4 Q9HAZ1 2/20 0.36
▸ PTGFR P43088 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ DHODH Q02127 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MMP2 P08253 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22179704 0.88 ADORA1 (0.39) NAMPTCTNNB1TCF7L2LMNAUSP2
SCHEMBL28443353 0.87 NAMPT (0.41) NAMPTCTNNB1TCF7L2LMNAUSP2
SCHEMBL29831787 0.87 NAMPT (0.41) NAMPTCTNNB1TCF7L2LMNAUSP2
SCHEMBL22179990 0.87 ADORA2A (0.38) CLK4PTGFRMAPTALDH1A1CA2
SCHEMBL30738416 0.87 ADORA2A (0.38) CLK4PTGFRMAPTALDH1A1CA2
SCHEMBL22179969 0.85 LMNA (0.43) LMNAUSP2CYP1A2CYP3A4CYP2D6
SCHEMBL30738512 0.85 LMNA (0.43) LMNAUSP2CYP1A2CYP3A4CYP2D6
SCHEMBL22180268 0.84 NAMPT (0.39) NAMPTCTNNB1TCF7L2LMNAUSP2
SCHEMBL22179997 0.83 NAMPT (0.38) NAMPTCTNNB1TCF7L2LMNAUSP2
SCHEMBL30738306 0.83 NAMPT (0.38) NAMPTCTNNB1TCF7L2LMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166119-B Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-05 — — CN disclosed
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-12-23 — — US disclosed
CN-113166119-A Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-23 — — CN disclosed
WO-2020135210-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2020-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF ADORA2A, ADORA1, ADORA3 NAMPT 169/4885CTNNB1 171/4885TCF7L2 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback